Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
OrthoPediatrics (KIDS) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +16.13% and +3.64%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity?
Is the Selloff in OrthoPediatrics Corp. (KIDS) Creating a Buying Opportunity...
Yahoo! Finance: News
OrthoPediatrics (NASDAQ:KIDS) Given "Buy" Rating at BTIG Research
BTIG Research restated a "buy" rating and issued a $24.00 target price on shares of OrthoPediatrics in a research note on Friday...
MarketBeat
OrthoPediatrics (NASDAQ:KIDS) Announces Quarterly Earnings Results
OrthoPediatrics (NASDAQ:KIDS - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.42) earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat
OrthoPediatrics (KIDS) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
OrthoPediatrics Q1 Earnings Call Highlights
OrthoPediatrics (NASDAQ:KIDS) opened 2026 with first-quarter revenue growth, improving profitability metrics, and what management described as early traction from a new wave of product launches. Executives emphasized patient impact as a core operating focus, noting the company supported the treatmen...
MarketBeat
OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -10.53% and +2.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
OrthoPediatrics Q1 2026 Earnings Call: Complete Transcript
read more...
Benzinga

Advertisement|Remove ads.